# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-003153
Filing Date
2014-05-12
Accepted
2014-05-12 16:53:46
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0314_actinium.htm | 10-Q | 635495
2 | SUBLEASE AGREEMENT | f10q0314ex10i_actinium.htm | EX-10.1 | 106013
3 | CERTIFICATION | f10q0314ex31i_actinium.htm | EX-31.1 | 18782
4 | CERTIFICATION | f10q0314ex32i_actinium.htm | EX-32.1 | 8010
| Complete submission text file | 0001213900-14-003153.txt |  | 5149295

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL INSTANCE DOCUMENT | atnm-20140331.xml | EX-101.INS | 643958
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | atnm-20140331.xsd | EX-101.SCH | 63256
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | atnm-20140331_cal.xml | EX-101.CAL | 24169
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | atnm-20140331_def.xml | EX-101.DEF | 221236
9 | XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT | atnm-20140331_lab.xml | EX-101.LAB | 492927
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | atnm-20140331_pre.xml | EX-101.PRE | 320985

Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 14834050
SIC: 6770 Blank Checks